DEFINITY

How to use DEFINITY®: Using the INTELLIPIN® (Dispensing Pin)


INTELLIPIN Dispensing Pin

INTELLIPIN® Dispensing Pin

For activated DEFINITY® (Perflutren Liquid Microsphere) Injectable Suspension only.

 

A Simple And Efficient Alternative To Needles

Instructions For Use. For single use only. Do not resterilize.

Intellipin 1
Following activation with VIALMIX®, remove DEFINITY® vial cap and insert INTELLIPIN® into vial.
Intellipin 2
Remove blue cap from female port of INTELLIPIN®, attach syringe to female port.
Intellipin 3
Invert DEFINITY® vial and withdraw using syringe.

Destroy after single use.


INTELLIPIN® Ordering Information

INDICATIONS

Activated DEFINITY® (Perflutren Lipid Microsphere) Injectable Suspension is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.

CONTRAINDICATIONS

Do not administer DEFINITY® to patients with known or suspected right-to-left, bi-directional or transient right-to-left cardiac shunts, by intra-arterial injection, or to patients with known hypersensitivity to perflutren.

IMPORTANT SAFETY INFORMATION

WARNING:  Serious Cardiopulmonary Reactions

Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following perflutren-containing microsphere administration [See WARNINGS AND PRECAUTIONS (5.1)].  Most serious reactions occur within 30 minutes of administration.

  • Assess all patients for the presence of any condition that precludes DEFINITY® administration [See CONTRAINDICATIONS (4)].

  • Always have resuscitation equipment and trained personnel readily available.


In post marketing use, rare but serious cardiopulmonary or anaphylactoid reactions have been reported during or shortly following perflutren-containing microsphere administration [See ADVERSE REACTIONS (6)]. The risk for these reactions may be increased among patients with unstable cardiopulmonary conditions [See Postmarketing Experience (6.2)]. It is not always possible to reliably establish a causal relationship to drug exposure due to the presence of underlying cardiopulmonary disease.

Please see full Prescribing Information, including boxed WARNING regarding serious cardiopulmonary reactions.

 

HOME